Drug Manufacturers - Specialty & Generic Companies By Ebitda
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
EBITDA
| EBITDA | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | LNTH | Lantheus Holdings | (0.07) | 3.61 | (0.26) | ||
| 2 | KALY | Kali Inc | 0.00 | 0.00 | 0.00 | ||
| 3 | NSRS | North Springs Resources | 0.00 | 0.00 | 0.00 | ||
| 4 | GELS | Gelteq Limited Ordinary | 0.05 | 19.88 | 1.07 | ||
| 5 | SXTC | China SXT Pharmaceuticals | (0.08) | 6.99 | (0.59) | ||
| 6 | RMTI | Rockwell Medical | (0.09) | 6.19 | (0.56) | ||
| 7 | BIOA | BioAge Labs, | (0.12) | 11.31 | (1.33) | ||
| 8 | YCBD-PA | cbdMD Inc | 0.15 | 6.26 | 0.96 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital. In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.